Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
Global clinical diagnostics company Novacyt introduce a new automated liquid handling system to meet growing demand for no manual pipetting in COVID-19 PCR testing.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
Here, we learn how international diagnostics group Novacyt are leading the innovation revolution in clinical diagnostics through discovery, design, and innovation.
